Skip to content
NxGEN Vector Solutions, LLC
  • About us
  • Our Technology
  • The Science
  • Cardiac Gene Therapy
  • Newsroom
  • Contact Us

January 30th, 2024 - Read the article entitled, ‘Lawsuit accuses Penn and gene therapy pioneer Dr. James Wilson of illegal conduct and sabotage’ published in the Philadelphia Business Journal concerning a federal lawsuit filed by NxGEN Vector Solutions against the University of Pennsylvania and James M. Wilson.

Click here to read the article.

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook

Related

Post navigation

A briefing document from the FDA for the Cellular, Tissue, and Gene Therapies Advisory Committee Meeting entitled, “Toxicity Risks of Adeno-associated Virus (AAV) Vectors for Gene Therapy” (September 2021), recognizes the importance of incorporating NxGEN’s Transformative Technology into AAV vectors to evade the immune system for durable transgene expression.
Read the article entitled ‘Penn Gene Therapy Program and Director to Depart University, Transfer to External Companies’ published in The Daily Pennsylvanian.

NxGEN Vector Solutions, LLC
455 Massachusetts Ave., N.W., Suite 369
Washington, D.C. 20001
p: 202.765.7475
www.nxgenvectorsolutions.com

About Us
• Our Founder and Members
Our Technology
• The Science
• The Technical Details
Newsroom
Construct Design & Consulting
Contact Us
• Privacy
  Facebook
  Twitter

copyright © 2018 NxGEN Vector Solutions, LLC